Hospital Universitario De Salamanca

Clinical research at Hospital Universitario De Salamanca focuses on Hemic and Lymphatic Diseases, with a strong emphasis on myelodysplastic syndrome in people with IPSS-R low- or intermediate-risk disease. The studies are designed to better understand treatment benefit and safety in a common blood disorder seen in the hematology setting.

• Evaluating a new oral azacitidine approach for myelodysplastic syndrome
• Comparing treatment effectiveness against best supportive care
• Assessing safety, response, and overall clinical value of a potential new therapy

This work aims to improve care for patients with lower-risk myelodysplastic syndrome by identifying more effective and practical treatment options.